相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Natural Polyphenols and their Synthetic Analogs as Emerging Anticancer Agents
Ramon Colomer et al.
CURRENT DRUG TARGETS (2017)
Triple-negative breast cancer: is there a treatment on the horizon?
Hui Yao et al.
ONCOTARGET (2017)
Epigallocatechin Gallate, a Green Tea Polyphenol Inhibits Mycobacterium smegmatis: In silico and In vitro Studies
S. Narayanan et al.
INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Molecular alterations in triple-negative breast cancer-the road to new treatment strategies
Carsten Denkert et al.
LANCET (2017)
Epigallocatechin gallate inhibits the growth of MDA-MB-231 breast cancer cells via inactivation of the β-catenin signaling pathway
On-Yu Hong et al.
ONCOLOGY LETTERS (2017)
Multi-level suppression of receptor-PI3K-mTORC1 by fatty acid synthase inhibitors is crucial for their efficacy against ovarian cancer cells
Renate Wagner et al.
ONCOTARGET (2017)
Fatty acid synthase expression and its association with clinico-histopathological features in triple-negative breast cancer
Ariadna Giro-Perafita et al.
ONCOTARGET (2017)
Quercetin regulates -catenin signaling and reduces the migration of triple negative breast cancer
Asha Srinivasan et al.
MOLECULAR CARCINOGENESIS (2016)
The Emerging Hallmarks of Cancer Metabolism
Natalya N. Pavlova et al.
CELL METABOLISM (2016)
Preclinical Evaluation of Fatty Acid Synthase and EGFR Inhibition in Triple-Negative Breast Cancer
Ariadna Giro-Perafita et al.
CLINICAL CANCER RESEARCH (2016)
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
Giampaolo Bianchini et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer
Jingdan Qiu et al.
JOURNAL OF CANCER (2016)
Molecular Pathways: Fatty Acid Synthase
Suzanne F. Jones et al.
CLINICAL CANCER RESEARCH (2015)
Dual Fatty Acid Synthase and HER2 Signaling Blockade Shows Marked Antitumor Activity against Breast Cancer Models Resistant to Anti-HER2 Drugs
Adriana Blancafort et al.
PLOS ONE (2015)
Inhibition of de novo Palmitate Synthesis by Fatty Acid Synthase Induces Apoptosis in Tumor Cells by Remodeling Cell Membranes, Inhibiting Signaling Pathways, and Reprogramming Gene Expression
Richard Ventura et al.
EBIOMEDICINE (2015)
Fatty acid synthase is a metabolic marker of cell proliferation rather than malignancy in ovarian cancer and its precursor cells
Daniel Veigel et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Cancer Treatment and Survivorship Statistics, 2014
Carol E. DeSantis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
Synthetic Inhibitors of Bacterial Cell Division Targeting the GTP-Binding Site of FtsZ
Laura B. Ruiz-Ayila et al.
ACS CHEMICAL BIOLOGY (2013)
Different fatty acid metabolism effects of (-)-Epigallocatechin-3-Gallate and C75 in Adenocarcinoma lung cancer
Joana Relat et al.
BMC CANCER (2012)
New Synthetic Inhibitors of Fatty Acid Synthase with Anticancer Activity
Carlos Turrado et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Flavonoids: Potential Wnt/beta-catenin signaling modulators in cancer
Nathalia G. Amado et al.
LIFE SCIENCES (2011)
A novel inhibitor of fatty acid synthase shows activity against HER2+breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines
Teresa Puig et al.
BREAST CANCER RESEARCH (2011)
Novel anti-fatty acid synthase compounds with anti-cancer activity in HER2(+) breast cancer
G. Oliveras et al.
TOWARD PERSONALIZED MEDICINE FOR CANCER (2010)
Epidermal growth factor receptor as a potential therapeutic target in triple-negative breast cancer
B. Corkery et al.
ANNALS OF ONCOLOGY (2009)
Interaction between fatty acid synthase- and ErbB-systems in ovarian cancer cells
Thomas W. Grunt et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Novel Inhibitors of Fatty Acid Synthase with Anticancer Activity
Teresa Puig et al.
CLINICAL CANCER RESEARCH (2009)
Combined effect of epigallocatechin gallate and triclosan on enoyl-ACP reductase of Mycobacterium tuberculosis
Shailendra Kumar Sharma et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
The crystal structure of a mammalian fatty acid synthase
Timm Maier et al.
SCIENCE (2008)
Fatty acid metabolism in breast cancer cells:: differential inhibitory effects of epigallocatechin gallate (EGCG) and C75
Teresa Puig et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
Javier A. Menendez et al.
NATURE REVIEWS CANCER (2007)
Green tea catechins potentiate triclosan binding to enoyl-ACP reductase from Plasmodium falciparum (PfENR)
Shailendra Kumar Sharma et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
mTOR signaling: implications for cancer and anticancer therapy
E Petroulakis et al.
BRITISH JOURNAL OF CANCER (2006)
Tamoxifen and epigallocatechin gallate are synergistically cytotoxic to MDA-MB-231 human breast cancer cells
K Chisholm et al.
ANTI-CANCER DRUGS (2004)
Evaluation of epigallocatechin gallate and related plant polyphenols as inhibitors of the FabG and FabI reductases of bacterial type II fatty-acid synthase
YM Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The galloyl moiety of green tea catechins is the critical structural feature to inhibit fatty-acid synthase
X Wang et al.
BIOCHEMICAL PHARMACOLOGY (2003)
Regulation of fatty acid synthase expression in breast cancer by sterol regulatory, element binding protein-1c
YA Yang et al.
EXPERIMENTAL CELL RESEARCH (2003)
分享论文
